Biosynthesis of Hibarimicins: III. Structures of New Hibarimicin-related Metabolites Produced by Blocked Mutants

Structures of metabolites produced by blocked mutants of Microbispora rosea subsp. hibaria TP-A0121, hibarimicin-producer, were determined by spectroscopic analysis. HMP-Y6 is the dimer of the west half of hibarimicin B, the aglycon of which is the genuine biosynthetic intermediate. HMP-P1 is the sh...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of antibiotics 2002/01/25, Vol.55(1), pp.61-70
Hauptverfasser: IGARASHI, YASUHIRO, KAJIURA, TAKAYUKI, FURUMAI, TAMOTSU, HORI, HIROSHI, HIGASHI, KAZUAKI, ISHIYAMA, TADAYUKI, URAMOTO, MASAKAZU, UEHARA, YOSHIMASA, OKI, TOSHIKAZU
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Structures of metabolites produced by blocked mutants of Microbispora rosea subsp. hibaria TP-A0121, hibarimicin-producer, were determined by spectroscopic analysis. HMP-Y6 is the dimer of the west half of hibarimicin B, the aglycon of which is the genuine biosynthetic intermediate. HMP-P1 is the shunt product arising from the release of a methanol molecule from hibarimicinone. HMP-P4, the glycoside of HMP-P1, is glycosylated with two amicetoses and two digitoxoses same as hibarimicin B. HMP-M1, M2, M3 and M4 are shunt products derived from the monomeric undecaketide intermediates.
ISSN:0021-8820
1881-1469
DOI:10.7164/antibiotics.55.61